om Oxygen Bio chief faked resume, audit body shows

om
Oxygen Bio chief faked resume, audit body shows 2:46 p.m. Sept. 26, 2011 - MarketWatch.com

UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Today - InvestorPlace.com
Oxygen Biotherapeutics (OXBT) Is Today's Perilous Reversal Stock 9:58 a.m. Nov. 15, 2013 - TheStreet.com
Today's Dead Cat Bounce Stock: Oxygen Biotherapeutics (OXBT) 9:45 a.m. Nov. 14, 2013 - TheStreet.com
4 Stock Jumps You Missed While Ogling the Twitter IPO 3:03 a.m. Nov. 12, 2013 - InvestorPlace.com
Oxygen Biotherapeutics Announces $6M in Net Proceeds from Exercise of Warrants 6:43 a.m. Nov. 8, 2013 - benzinga.com
Oxygen Biotherapeutics (OXBT) Showing Signs Of A Dead Cat Bounce Today 9:45 a.m. Nov. 7, 2013 - TheStreet.com
Watch Out: Barbarians At The Gate For Oxygen Biotherapeutics (OXBT) 10:27 a.m. Nov. 5, 2013 - TheStreet.com
UPDATE: Oxygen Biotherapeutics Reports Deal to Buy Phase 3, FDA Fast-Track Designated Levosimendan from Phyxius Pharma 2:47 p.m. Oct. 21, 2013 - benzinga.com
10-Q: OXYGEN BIOTHERAPEUTICS, INC. 4:05 p.m. Sept. 17, 2013 - Edgar Online - (EDG = 10Q, 10K)
Oxygen Biotherapeutics Sends Letter to Holds, Discusses Progress, Prelim. Results in Trials 6:33 a.m. Aug. 7, 2013 - benzinga.com
Oxygen Biotherapeutics Prices Public Offering with Gross Proceeds of $5.4 Million 6:32 a.m. July 22, 2013 - benzinga.com
Oxygen Biotherapeutics Announces Progress in its Phase IIb Clinical Trial of Oxycyte for the Treatment of Traumatic Brain Injury 6:46 a.m. July 1, 2013 - benzinga.com
Oxygen Biotherapeutics Makes Recent Progress In An Under-Met Indication 2:16 p.m. June 28, 2013 - Seeking Alpha
10-K: OXYGEN BIOTHERAPEUTICS, INC. 3:17 p.m. June 26, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech Movers: Chelsea Doubles, Vivus Dips 3:15 a.m. Feb. 25, 2013 - InvestorPlace.com
Oxygen Biotherapeutics Announces Deal for Up to $2.1M in Financing 8:00 a.m. Feb. 22, 2013 - benzinga.com
Oxygen Biotherapeutics Reports Tentative Settlement of Litigation 10:05 a.m. Feb. 20, 2013 - benzinga.com
Oxygen Biotherapeutics Announces License, Supply Deal for Dermacyte Products with Valor Cosmetics Unit 4:16 p.m. Feb. 11, 2013 - benzinga.com
Oxygen Biotherapeutics, US Army ISR Sign Cooperative R&D Deal to Study Effects of Oxycyte on Ex Vivo Platelet Function 7:33 a.m. Feb. 6, 2013 - benzinga.com
10-Q: OXYGEN BIOTHERAPEUTICS, INC. 4:41 p.m. Dec. 14, 2012 - Edgar Online - (EDG = 10Q, 10K)


Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
Oxygen Biotherapeutics Closes the Acquisition of Phyxius Pharma Assets Related to Levosimendan; John Kelley Appointed CEO of Oxygen Biotherapeutics 7:45 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR 10:35 a.m. Nov. 11, 2013 - ACCESSWIRE
Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises 7:25 a.m. Nov. 8, 2013 - BusinessWire
Oxygen Biotherapeutics (OXBT) Rise Sheds Light On OxySure Systems (OXYS) 12:00 p.m. Nov. 7, 2013 - ACCESSWIRE
Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark 8:48 a.m. Nov. 6, 2013 - PR Newswire
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
SmallCapTraders.Com Initiates Coverage of (NASDAQ: OXBT) and Issues Micro Cap Watch List 6:01 a.m. Nov. 1, 2013 - Marketwire
Phyxius Pharma in Conjunction with Oxygen Biotherapeutics Announces New Evidence That Levosimendan Can Reduce Mortality in Heart Surgery Patients 8:59 a.m. Oct. 30, 2013 - BusinessWire
Phyxius Pharma in Conjunction with Oxygen Biotherapeutics Announces New Evidence That Levosimendan Can Reduce Mortality in Heart Surgery Patients 7:45 a.m. Oct. 30, 2013 - BusinessWire
Commencement of Clinical Trials, Financial Results, Upcoming Earnings Releases, and Asset Acquisitions - Research Report on Questcor, Jazz Pharmaceuticals, Ariad, and USANA 7:00 a.m. Oct. 25, 2013 - PR Newswire
MDVN, OXBT, PTIE and SYMM added to NASDAQ Active Stock Watch List at EPR 8:30 a.m. Oct. 23, 2013 - ACCESSWIRE
Oxygen Biotherapeutics Signs Agreement to Acquire Phase 3, FDA Fast Track Product to Pursue Potential $600 Million Cardiovascular Market 3:45 p.m. Oct. 21, 2013 - BusinessWire
Oxygen Biotherapeutics Submits to FDA Results of Requested Nonclinical Studies 8:24 a.m. Sept. 23, 2013 - BusinessWire
Oxygen Biotherapeutics to Present at Aegis Capital Healthcare Conference in Las Vegas on September 27, 2013 7:45 a.m. Sept. 19, 2013 - BusinessWire
Oxygen Biotherapeutics Strengthens Balance Sheet Through $4.6 Million Debt Conversion 8:00 a.m. Sept. 18, 2013 - BusinessWire
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Oxygen Biotherapeutics Issued U.S. Patent for Dermatologic Indications 8:00 a.m. Sept. 10, 2013 - BusinessWire
CORRECTING and REPLACING Oxygen Biotherapeutics Issues Letter to Shareholders 11:13 a.m. Aug. 7, 2013 - BusinessWire

$OXBT News

The roller-coaster stock in health care that is Oxygen Biotherapeutics 12:54 p.m. Nov. 6, 2013 - Russ Britt
Big earnings Friday: Rick’s Cabaret, Ocean Power 5:30 a.m. Dec. 14, 2012 - MarketWatch
Oxygen Biotherapeutics names new chairman 8:55 a.m. Oct. 1, 2011 - MarketWatch.c